PharmSol has built a strong reputation over the past two decades by offering auditing and compliance services not only to Pharma manufacturers and marketers but to every member within the pharmaceutical value chain. Since 2007, PharmSol has specialized in conducting third-party Good Manufacturing Practice (GMP) audits to ensure adherence to major global standards, including Eudralex Volume 4, US FDA 21 CFR Part 210, and the PIC/S Guide to GMP for Medicinal Products, as of its latest update in August 2023. This expertise has allowed PharmSol to remain at the forefront of regulatory compliance in the industry.

PharmSol’s audit expertise encompasses multiple facets or regulatory compliance and quality assurance. Through this array of audit services, PharmSol supports clients in maintaining compliance, enhancing quality, and minimizing risks throughout the product lifecycle.

Here is a list of the audit services offered

With the above, PharmSol leverages its deep expertise in EU market access and compliance services to create customized solutions that help manufacturing facilities worldwide achieve EU GMP certification. PharmSol's unique approach enables both Finished Dosage Form and Active Pharmaceutical Ingredient (API) manufacturers in regions like India, China, Europe, and the US to gain EU GMP certification swiftly and efficiently.